Generic placeholder image

Current Pediatric Reviews

Editor-in-Chief

ISSN (Print): 1573-3963
ISSN (Online): 1875-6336

Research Article

Potential Role of Bilirubin in Preventing Retinopathy of Prematurity

Author(s): Hassan Boskabadi, Naser Shoeibi, Fatemeh Bagheri, Nafiseh Pourbadakhshan, Ali Moradi and Maryam Zakerihamidi*

Volume 19, Issue 2, 2023

Published on: 05 September, 2022

Page: [197 - 202] Pages: 6

DOI: 10.2174/1573396318666220819151154

Price: $65

Abstract

Background: One of the most common problems in preterm neonates is retinopathy of prematurity (ROP). It has been shown antioxidants may be effective in preventing the development and progression of ROP. Considering the antioxidant properties of bilirubin, we decided to investigate the bilirubin level in neonates with ROP and compare it with healthy neonates.

Methods: This case-control study was performed on VLBW neonates admitted to the NICU of Ghaem Hospital in Mashhad between 2014 and 2020 for a Jaundice evaluation. Complete neonate’s characteristics, maternal history and laboratory results were collected in a questionnaire. Then the neonates were examined for ROP by a fellowship of the retina of an ophthalmologist at 32 weeks or four weeks after birth. The highest bilirubin levels during their hospitalization were also recorded.

Results: Of 427 neonates examined, 121 (37.7%) had a normal eye examination, and 266 (62.3%) had ROP. The mean weight, gestational age and bilirubin were 1455.8 ± 431.4 grams, 31.6 ± 2.3 weeks and 8.8 ± 2.4 mg/dl, respectively. There was a significant difference between controls and neonates with ROP with regard to birth weight, duration of intermittent positive pressure ventilation (IPPV), duration of oxygen therapy, first and fifth minute Apgar scores, the maximum level of bilirubin and gestational age (P < 0.05). It was observed that the maximum level of bilirubin was lower in neonates with higher stages of ROP.

Conclusion: According to the results of this study, higher levels of bilirubin in neonates may be a protective factor against ROP. Moreover, increased levels of bilirubin are associated with reduced severity of ROP. Therefore, prophylaxis phototherapy in premature infants may need to be reconsidered.

Keywords: Premature infant, antioxidant, hyperbilirubinemia, retinopathy of prematurity (ROP), necrotizing enterocolitis (NEC), intraventricular hemorrhage (IVH), periventricular leukomalacia (PVL).

Graphical Abstract
[1]
Bagheri F, Askari Hosseni Z. Developmental disorders in preterm neonates during the first two years of life using the ages and stages questionnaire. J Babol Univ Medical Sci 2016; 18(2): 7-13.
[2]
Abrishami M, Maemori G-A, Boskabadi H, Yaeghobi Z, Mafi-Nejad S, Abrishami M. Incidence and risk factors of retinopathy of prematurity in mashhad, northeast iran. Iran Red Crescent Med J 2013; 15(3): 229-33.
[http://dx.doi.org/10.5812/ircmj.4513] [PMID: 23984003]
[3]
Akkoyun I, Oto S, Yilmaz G, et al. Risk factors in the development of mild and severe retinopathy of prematurity. J AAPOS 2006; 10(5): 449-53.
[http://dx.doi.org/10.1016/j.jaapos.2006.05.007] [PMID: 17070481]
[4]
Kim SJ, Port AD, Swan R, Campbell JP, Chan RVP, Chiang MF. Retinopathy of prematurity: A review of risk factors and their clinical significance. Surv Ophthalmol 2018; 63(5): 618-37.
[http://dx.doi.org/10.1016/j.survophthal.2018.04.002] [PMID: 29679617]
[5]
Darlow BA, Hutchinson JL, Henderson-Smart DJ, Donoghue DA, Simpson JM, Evans NJ. Prenatal risk factors for severe retinopathy of prematurity among very preterm infants of the Australian and New Zealand Neonatal Network. Pediatrics 2005; 115(4): 990-6.
[http://dx.doi.org/10.1542/peds.2004-1309] [PMID: 15805375]
[6]
Chen J, Smith LE. Retinopathy of prematurity. Angiogenesis 2007; 10(2): 133-40.
[http://dx.doi.org/10.1007/s10456-007-9066-0] [PMID: 17332988]
[7]
Shah VA, Yeo CL, Ling YL, Ho LY. Incidence, risk factors of retinopathy of prematurity among very low birth weight infants in Singapore. Ann Acad Med Singap 2005; 34(2): 169-78.
[PMID: 15827664]
[8]
Boskabadi H, Navaee Boroujeni A, Mostafavi-Toroghi H, et al. Prooxidant-antioxidant balance in perinatal asphyxia. Indian J Pediatr 2014; 81(3): 248-53.
[http://dx.doi.org/10.1007/s12098-013-1239-9] [PMID: 24146060]
[9]
Panfoli I, Candiano G, Malova M, et al. Oxidative stress as a primary risk factor for brain damage in preterm newborns. Front Pediatr 2018; 6: 369.
[http://dx.doi.org/10.3389/fped.2018.00369] [PMID: 30555809]
[10]
Buonocore G, Perrone S, Bracci R. Free radicals and brain damage in the newborn. Biol Neonate 2001; 79(3-4): 180-6.
[http://dx.doi.org/10.1159/000047088] [PMID: 11275648]
[11]
Rivera JC, Sapieha P, Joyal J-S, et al. Understanding retinopathy of prematurity: Update on pathogenesis. Neonatology 2011; 100(4): 343-53.
[http://dx.doi.org/10.1159/000330174] [PMID: 21968165]
[12]
Hartnett ME. The effects of oxygen stresses on the development of features of severe retinopathy of prematurity: Knowledge from the 50/10 OIR model. Documenta ophthalmologica 2010; 120(1): 25-39.
[13]
Boskabadi H, Mollaei MK, Zakerihamidi M, Mobarhan MG, Bagheri F. The effect of exchange transfusion on prooxidant-antioxidant balance in newborns Jaundice. Biomed Res Ther 2018; 5(3): 2119-29.
[http://dx.doi.org/10.15419/bmrat.v5i3.425]
[14]
Boskabadi H, Kalate M. Effect of phototherapy on pro-oxidant/antioxidant balance in newborns with Jaundice. Biomed Res Ther 2018; 5(7): 2432-9.
[http://dx.doi.org/10.15419/bmrat.v5i7.455]
[15]
Stocker R, Glazer AN, Ames BN. Antioxidant activity of albumin-bound bilirubin. Proc Natl Acad Sci USA 1987; 84(16): 5918-22.
[http://dx.doi.org/10.1073/pnas.84.16.5918] [PMID: 3475708]
[16]
Barañano DE, Rao M, Ferris CD, Snyder SH. Biliverdin reductase: A major physiologic cytoprotectant. Proc Natl Acad Sci USA 2002; 99(25): 16093-8.
[http://dx.doi.org/10.1073/pnas.252626999] [PMID: 12456881]
[17]
Sedlak TW, Snyder SH. Bilirubin benefits: Cellular protection by a biliverdin reductase antioxidant cycle. Pediatrics 2004; 113(6): 1776-82.
[http://dx.doi.org/10.1542/peds.113.6.1776] [PMID: 15173506]
[18]
Batta A. Bilirubin as savior of biological system. Int J Curr Res Med Sci 2017; 3(2): 21-7.
[http://dx.doi.org/10.22192/ijcrms.2017.03.02.004]
[19]
Fereshtehnejad SM, Poorsattar Bejeh Mir K, Poorsattar Bejeh Mir A, Mohagheghi P. Evaluation of the possible antioxidative role of bilirubin protecting from free radical related illnesses in neonates. Acta Med Iran 2012; 50(3): 153-63.
[PMID: 22418983]
[20]
Akkawi MT, Shehadeh MM, Shams ANA, et al. Incidence and risk factors of retinopathy of prematurity in three neonatal intensive care units in Palestine. BMC Ophthalmol 2019; 19(1): 189.
[http://dx.doi.org/10.1186/s12886-019-1180-4] [PMID: 31429728]
[21]
Fauchère J-C, Meier-Gibbons FE, Koerner F, Bossi E. Retinopathy of prematurity and bilirubin--no clinical evidence for a beneficial role of bilirubin as a physiological anti-oxidant. Eur J Pediatr 1994; 153(5): 358-62.
[http://dx.doi.org/10.1007/BF01956419] [PMID: 8033927]
[22]
DeJonge MH, Khuntia A, Maisels MJ, Bandagi A. Bilirubin levels and severe retinopathy of prematurity in infants with estimated gestational ages of 23 to 26 weeks. J Pediatr 1999; 135(1): 102-4.
[http://dx.doi.org/10.1016/S0022-3476(99)70336-7] [PMID: 10393613]
[23]
Mehmet S, Fusun A, Sebnem C, et al. One-year experience in the retinopathy of prematurity: Frequency and risk factors, short-term results and follow-up. Int J Ophthalmol 2011; 4(6): 634-40.
[PMID: 22553735]
[24]
Romeo M, Tina L, Scuderi A, Di MP, Caracciolo M, Distefano G. Variations of blood bilirubin levels in the newborn with and without retinopathy of prematurity (ROP). Med Surg Pediatr 1994; 16(1): 59-62.
[25]
Milner JD, Aly HZ, Ward LB, El-Mohandes A. Does elevated peak bilirubin protect from retinopathy of prematurity in very low birthweight infants. J Perinatol 2003; 23(3): 208-11.
[http://dx.doi.org/10.1038/sj.jp.7210887] [PMID: 12732858]
[26]
Aaberg T, Ben-Sira I, Charles S, et al. An international classification of retinopathy of prematurity. II. The classification of retinal detachment. Arch Ophthalmol 1987; 105(7): 906-12.
[http://dx.doi.org/10.1001/archopht.1987.01060070042025] [PMID: 3606449]
[27]
Riordan-Eva P, Whitcher J, Vaughan-Whitehead D, Asbury T. Vaughan & Asbury's general ophthalmology. University of Ljubljana: Slovenia 2011; pp. 208-11.
[28]
Shah PK, Prabhu V, Karandikar SS, Ranjan R, Narendran V, Kalpana N. Retinopathy of prematurity: Past, present and future. World J Clin Pediatr 2016; 5(1): 35-46.
[http://dx.doi.org/10.5409/wjcp.v5.i1.35] [PMID: 26862500]
[29]
Canto L, Huerva V, Perez J, Ascaso F, Palomar A. Is bilirubin a protective factor on lite development of retinopathy of prematurity? Arch Soc Esp Oftalmol 1999; 74: 205-10.
[30]
Kao JS, Dawson JD, Murray JC, et al. Possible roles of bilirubin and breast milk in protection against retinopathy of prematurity. Acta Paediatr 2011; 100(3): 347-51.
[http://dx.doi.org/10.1111/j.1651-2227.2010.02069.x] [PMID: 20969622]
[31]
Hegyi T, Goldie E, Hiatt M. The protective role of bilirubin in oxygen-radical diseases of the preterm infant. Am J Perinatol 1994; 14(4): 296-300.
[32]
Gaton DD, Gold J, Axer-Siegel R, Wielunsky E, Naor N, Nissenkorn I. Evaluation of bilirubin as possible protective factor in the prevention of retinopathy of prematurity. Br J Ophthalmol 1991; 75(9): 532-4.
[http://dx.doi.org/10.1136/bjo.75.9.532] [PMID: 1911654]
[33]
Yeo KL, Perlman M, Hao Y, Mullaney P. Outcomes of extremely premature infants related to their peak serum bilirubin concentrations and exposure to phototherapy. Pediatrics 1998; 102(6): 1426-31.
[http://dx.doi.org/10.1542/peds.102.6.1426] [PMID: 9832580]
[34]
Fujiwara R, Haag M, Schaeffeler E, Nies AT, Zanger UM, Schwab M. Systemic regulation of bilirubin homeostasis: Potential benefits of hyperbilirubinemia. Hepatology 2018; 67(4): 1609-19.
[http://dx.doi.org/10.1002/hep.29599] [PMID: 29059457]
[35]
Hosono S, Ohno T, Kimoto H, et al. No clinical correlation between bilirubin levels and severity of retinopathy of prematurity. J Pediatr Ophthalmol Strabismus 2002; 39(3): 151-6.
[http://dx.doi.org/10.3928/0191-3913-20020501-06] [PMID: 12051280]
[36]
Boskabadi H, Marefat M, Maamouri G, et al. Evaluation of pro-oxidant antioxidant balance in retinopathy of prematurity. Eye (Lond) 2022; 36(1): 148-52.
[PMID: 33649574]
[37]
Azami M, Jaafari Z, Rahmati S, Farahani AD, Badfar G. Prevalence and risk factors of retinopathy of prematurity in Iran: A systematic review and meta-analysis. BMC Ophthalmol 2018; 18(1): 83.
[http://dx.doi.org/10.1186/s12886-018-0732-3] [PMID: 29606108]
[38]
Nakayama M, Takahashi K, Komaru T, et al. Increased expression of heme oxygenase-1 and bilirubin accumulation in foam cells of rabbit atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2001; 21(8): 1373-7.
[http://dx.doi.org/10.1161/hq0801.093592] [PMID: 11498468]
[39]
Stocker R. Antioxidant activities of bile pigments. Antioxid Redox Signal 2004; 6(5): 841-9.
[PMID: 15345144]
[40]
Maruhashi T, Kihara Y, Higashi Y. Bilirubin and endothelial function. J Atheroscler Thromb 2019; 26(8): 688-96.
[http://dx.doi.org/10.5551/jat.RV17035] [PMID: 31270300]
[41]
Boskabadi H, Ghayour-Mobarhan M, Bagheri F, Pourbadakhshan N. The comparison of pro-oxidant-antioxidant balance in physiologic and pathologic jaundice. Iran J Pediatr 2020; 30(1): e98117.
[http://dx.doi.org/10.5812/ijp.98117]
[42]
Li S-Y, Fu ZJ, Lo AC. Hypoxia-induced oxidative stress in ischemic retinopathy. Oxid Med Cell Longev 2012; 2012: 426769.
[http://dx.doi.org/10.1155/2012/426769]
[43]
Ying G-S, Bell EF, Donohue P, Tomlinson LA, Binenbaum G. Perinatal risk factors for the retinopathy of prematurity in postnatal growth and Rop study. Ophthalmic Epidemiol 2019; 26(4): 270-8.
[http://dx.doi.org/10.1080/09286586.2019.1606259] [PMID: 31012360]
[44]
Mani K, Jeganathan S. Incidence and risk factors contributing to ROP: Study from neonatal care unit--South India. J Evol Med Dent Sci 2016; 5(7): 336-40.
[http://dx.doi.org/10.14260/jemds/2016/73]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy